Literature DB >> 15098931

Survival of trauma-injured neurons in rat brain by treatment with proline-rich peptide (PRP-1): an immunohistochemical study.

Silva S Abrahamyan1, John S Sarkissian, Irina B Meliksetyan, Armen A Galoyan.   

Abstract

The objective of this immunohistochemical research was to reveal the distribution of a proline-rich peptide-1 (PRP-1) in various brain structures of intact and trauma-injured rats and to identify the mechanisms of promotion of neuronal recovery processes following PRP-1 treatment. PRP-1, produced by bovine hypothalamic magnocellular cells and consisting of 15 amino acid residues, is a fragment of neurophysin vasopressin associated glycoprotein isolated from bovine neurohypophysis neurosecretory granules. PRP-1-immunoreactivity (PRP-1-IR) was detected in the brain of intact rats in the neurons of paraventricular (PVN) and supraoptic (SON) nuclei in the hypothalamus, in almost all cell groups in the medulla oblongata, in Purkinje and some cerebellar nuclei cells, and in nerve fibers. At 3 weeks after hemisection of the spinal cord (SC) an asymmetry of PRP-1 localization in the PVN and SON was observed: no PRP-1-IR was exhibited at the affected sides of both nuclei. Daily intramuscular administration of PRP-1 for 3 weeks significantly increased the number of PRP-1-immunoreactive (PRP-1-Ir) varicose nerve fibers, and cells in PVN and SON and in cell groups of the limbic system and brain stem. Tanycytes in the median eminence and covering ependyma also demonstrated strong PRP-1-IR. PRP-1 treatment also activated neuropeptide Y-IR (NPY-IR) in nerve fibers and immunophilin fragment-IR (IphF-IR) in lymphocytes and nerve cells. A strong increase of PRP-1-IR was observed in the PVN and SON of SC-injured rats following the treatment with another PRP (PRP-3). Preliminary physiological data demonstrate that PRP-3 is more "aggressive" in the recovery processes than PRP-1. Based on the findings regarding PRP action on neurons survival, axons regeneration, and the number of IphF-Ir lymphocytes and NPY-Ir nerve fibers, PRP is suggested to act as a neuroprotector, functioning as a putative neurotransmitter and immunomodulator.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15098931     DOI: 10.1023/b:nere.0000018840.19073.0b

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  61 in total

Review 1.  Receptors for neuropeptide Y: multiple subtypes and multiple second messengers.

Authors:  M C Michel
Journal:  Trends Pharmacol Sci       Date:  1991-10       Impact factor: 14.819

Review 2.  The role of neuropeptide Y in cardiovascular regulation.

Authors:  P Walker; E Grouzmann; M Burnier; B Waeber
Journal:  Trends Pharmacol Sci       Date:  1991-03       Impact factor: 14.819

3.  Cytological and cytochemical (RNA) studies on rubral neurons after unilateral rubrospinal tractotomy: the impact of GM1 ganglioside administration.

Authors:  K D Barron; M Banerjee; M P Dentinger; M E Scheibly; R Mankes
Journal:  J Neurosci Res       Date:  1989-03       Impact factor: 4.164

4.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

Review 5.  Peptides in motoneurons.

Authors:  G Raivich; M Reddington; C A Haas; G W Kreutzberg
Journal:  Prog Brain Res       Date:  1995       Impact factor: 2.453

6.  Transplants and neurotrophic factors prevent atrophy of mature CNS neurons after spinal cord injury.

Authors:  B S Bregman; E Broude; M McAtee; M S Kelley
Journal:  Exp Neurol       Date:  1998-01       Impact factor: 5.330

7.  Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis.

Authors:  M Deckert-Schlüter; H Bluethmann; A Rang; H Hof; D Schlüter
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

8.  Major role of 3',5'-cyclic adenosine monophosphate-dependent protein kinase A pathway in corticotropin-releasing factor gene expression in the rat hypothalamus in vivo.

Authors:  K Itoi; N Horiba; F Tozawa; Y Sakai; K Sakai; K Abe; H Demura; T Suda
Journal:  Endocrinology       Date:  1996-06       Impact factor: 4.736

9.  Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells.

Authors:  S Mansour-Robaey; D B Clarke; Y C Wang; G M Bray; A J Aguayo
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

10.  Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism.

Authors:  J Wang; A J Dunn
Journal:  Neurochem Int       Date:  1998-08       Impact factor: 3.921

View more
  2 in total

1.  Protective effects of hypothalamic proline-rich peptide and cobra venom Naja Naja Oxiana on dynamics of vestibular compensation following unilateral labyrinthectomy.

Authors:  Armen A Galoyan; Naser Khalaji; Lilja E Hambardzumyan; Larisa P Manukyan; Irina B Meliksetyan; Vergine A Chavushyan; Vaghinak H Sarkisian; John S Sarkissian
Journal:  Neurochem Res       Date:  2010-08-12       Impact factor: 3.996

2.  Glutamate-related gene expression changes with age in the mouse auditory midbrain.

Authors:  Sherif F Tadros; Mary D'Souza; Martha L Zettel; Xiaoxia Zhu; Nicole C Waxmonsky; Robert D Frisina
Journal:  Brain Res       Date:  2006-11-17       Impact factor: 3.252

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.